Characterization of Sp17: a ubiquitous three domain protein that binds heparin by WEN, Ying et al.
Biochem. J. (2001) 357, 25–31 (Printed in Great Britain) 25
Characterization of Sp17 : a ubiquitous three domain protein that
binds heparin
Ying WEN1, Richard T. RICHARDSON, Esther E. WIDGREN and Michael G. O’RAND2
Department of Cell Biology and Anatomy, CBg7090, 210 Taylor Hall, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, U.S.A.
Sp17 is a protein that was originally thought to be expressed
exclusively in the testis and whose primary function was binding
to the extracellular matrix of the oocyte. Several recent reports
have implicated Sp17 as having a role in cell–cell adhesion
and}or cell migration in transformed, lymphocytic and haemato-
poietic cells, possibly through its interaction with extracellular
heparan sulphate. In the present study, we report that Sp17’s
central domain (amino acids 61–117), spanning exon 3, is critical
for heparin binding. Sp17 has two additional functional domains,
an N-terminal domain similar to the dimer-interaction site in the
cAMP-dependent protein kinase IIα regulatory subunit and a C-
terminal calmodulin-binding domain. The mouse gene for Sp17
is 6.5 kb and contains four exons. Although Sp17 expression is
INTRODUCTION
The extracellular matrix influences the behaviour of cells through
its interaction with the cell’s repertoire of surface receptors.
Perhaps nowhere else is this more dramatic than in the sudden
release of the apical granule (acrosome) of the sperm cell as it
encounters the oocyte–cumulus complex, undergoing the acro-
some reaction in preparation for penetrating the zona pellucida.
To adhere to the extracellular matrix of the oocyte, spermatozoa
employ one of the most adhesive, high-affinity (K
D
approx.
5.6¬10−"$ M) binding molecules present after the acrosome
reaction, the zona pellucida-binding protein, Sp17 [1,2]. This
molecule, present in every mammalian species examined, was
first described as a member of the rabbit sperm antigen family of
proteins, with lectin-like properties that bound sulphated com-
plex carbohydrates, such as fucoidin, dextran sulphate and
heparin [2]. Originally thought to be expressed exclusively in the
testis and to be present on the surface of acrosome-reacted
spermatozoa, Sp17’s primary function was binding to the extra-
cellular matrix of the oocyte [1]. Moreover, the observation that
Sp17-transfected COS cells expressed Sp17 on their surfaces and
bound native zona pellucida [3] reinforced this hypothesis, in
spite of the fact that Sp17 lacks a signal sequence or an obvious
transmembrane domain.
Recently, new data about Sp17 have been reported from
transformed cells and normal somatic cells. Using mRNA
differential display, Dong et al. [4] found an increased expression
of Sp17 in three metastatic cell lines derived from an in itro
transformed keratinocyte line (Pam 212). Lacy and Sanderson [5]
reported Sp17 to be expressed by human haematopoietic cell
lines, myeloma cells and normal peripheral blood mononuclear
cells. Present on the surface of these cells, Sp17 evidently
promotes cell–cell adhesion through its interaction with
syndecan-1 heparan sulphate chains. Similarly, during a mucosal
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highest in the testis, it is present in all of the mouse somatic
tissues examined and is highly conserved throughout all mam-
malian species. Sp17’s central domain, which is necessary for
heparin binding, exhibits the greatest sequence divergence of all
three domains. The Sp17 gene is induced in metastatic cells and
during mucosal immune responses, and the protein appears to
play an important role in cell migration and}or adhesion in
somatic cells, as well as in male germ cells.
Key words: calmodulin, calmodulin-binding protein, heparan-
binding protein, sulphated-carbohydrate-binding protein,
syndecan.
immune response to bovine rotavirus infection, Sp17 gene
expression is induced, leading to the hypothesis that Sp17 is
involved in immune cell migration [6]. Consequently, Sp17
expression is neither testis-specific, as originally reported from
Northern-blot data [1], nor is it exclusively for binding to the
zona pellucida of the oocyte. Indeed, the three initial protein
domains proposed for Sp17, the N-terminal dimer interact-
ion domain, the sulphated carbohydrate-binding domain and the
C-terminal calmodulin-binding domain [7], would all seem to be
of potential importance in somatic cells ; the dimer interaction
site for interaction with A-kinase anchoring proteins (AKAPs)
[8–10], and the calmodulin-binding site for the proteolytic release
of calmodulin at the appropriate time and place [11]. The sul-
phated carbohydrate-binding domain appears to be of direct
relevance to Sp17’s binding to heparan sulphate chains of
syndecan and its ability to aggregate certain transformed cells.
Because of the importance of Sp17’s ability to bind and
aggregate transformed cells, in the present paper we have
examined the binding of Sp17 to the sulphated carbohydrate,
heparin. We also report that Sp17 is present in all somatic tissues
examined, although at a lower level than in the testis, and that
the major sulphated carbohydrate-binding domain appears to
span exon 3. From a comparison of Sp17 protein sequences from
nine different species, it appears that the sulphated carbohydrate-
binding domain is the most variable part of the protein.
MATERIALS AND METHODS
Materials
All chemicals and reagents were of molecular biology grade.
Restriction enzymes and Taq DNA polymerase were purchased
from Boehringer Mannheim. DNA was sequenced in both
forward and reverse directions at the University of North
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Carolina at Chapel Hill Automated DNA Sequencing Facility
on a Model 373A DNA Sequencer (Applied Biosystems; Foster
City, CA, U.S.A.) using the Taq DyeDeoxy4 Terminator Cycle
Sequencing kit (Applied Biosystems).
Bacterial expression and purification of recombinant proteins





) were made as described previously [11]. To make









), DNA was amplified by PCR
using specific primers containing 5« BamHIand 3« KpnI restriction





GGGGCTAAGGTTGATGACCGCTTC-3« and the antisense
primer was 5«-CGGGGTACCGCCAGTGCCCTCAATTGT-





TGTCGATTCCATTTTCC-3« and the antisense primer was
5«-CGGGGTACCTCATTCAGCTGGATCAAAGTT-3«. The
amplified PCR products were cloned into pQE-30 pre-digested
with BamHI and KpnI, and the correctness of the inserts verified
by DNA sequencing. The recombinant DNA was transformed
into bacterial cells and recombinant proteins purified using the
Ni#+ nitrilotriacetate column, as described previously [1].
Heparin-binding assays
All binding assays were performed at room temperature. To
perform the ["#&I]heparin–albumin binding assay, 5 pmol of
recombinant protein were air-dried on Immulon ‘Removawell ’
strips (Dynatech Laboratories, Chantilly, VA, U.S.A.) and
blocked for 90 min in the heparin-binding buffer (50 mM Tris,
pH 7.5, 150 mM NaCl, 1 mM CaCl
#
and 0.05% Tween 20) with
5% BSA. The plate was incubated in the same buffer containing
increasing amounts of ["#&I]heparin–albumin for 150 min, washed
with the heparin-binding buffer three times, and the amount of
heparin bound was detected by removing individual wells from
the strip and counting in a Pharmacia γ-radiation counter. To
show the specificity of the binding, the plate was incubated with
a saturating amount (0.8 µg) of ["#&I]heparin–albumin in the
presence of increasing amounts of unlabelled heparin.
PCR of Sp17 from multiple tissues
The sense primer for amplifying the Sp17 open reading frame
(ORF) from Mouse Multiple Tissue cDNA Panel I (ClonTech
Laboratories) was 5«-ATGTCGATTCCTTTCTCCAACACC-
CAC-3« and the antisense primer was 5«-TCAATTGTCTGCC-
TCTTCTTTCAGATTCTC-3«. PCR was performed with the
following conditions: cycle 1, 94 °C for 2 min 30 s, 58 °C for
1 min 30 s and 72 °C for 2 min; cycles 2–30, 94 °C for 45 s, 58 °C
for 1 min 30 s and 72 °C for 2 min; cycle 31, 94 °C for 45 s,
58 °C for 1 min 30 s and 72 °C for 7 min. The PCR products
were analysed on 1% agarose gels (Fisher Scientific).
mRNA dot blot
Mouse RNA Master Blot was purchased from ClonTech
Laboratories and probed with mouse testis Sp17 ORF. The
probe was made using the North2South4 Biotin Random Prime
kit (Pierce, Rockford, IL, U.S.A.) and hybridized and developed
using the North2South4 Chemiluminescent Nucleic Acid
Hybridization and Detection kit (Pierce). The level of Sp17
expression was analysed with GelExpert software (Nucleotech
Corp., San Carlos, CA, U.S.A.).
Cloning of mouse heart and kidney Sp17
Mouse heart and kidney polyadenylated RNA were purchased
from ClonTech Laboratories. Mouse heart and kidney Sp17
ORFs were obtained by performing 3«-rapid amplification of
cDNA ends (Gibco BRL), using gene-specific primers to mouse
testis Sp17.
Western blot
The mouse multiple tissue blot was purchased from Geno
Technology (St Louis, MO, U.S.A.). Tissue lysate (75 µg) was
loaded into each lane. The blot was probed with affinity-purified
rabbit anti-rabbit Sp17, as described previously [11]. Rabbit
anti-rabbit Sp17 was made as described by Richardson et al. [1],
and affinity-purified using the SulfoLink Coupling Gel (Pierce)
coupled with recombinant rabbit Sp17. The blot shown in Figure
3 was probed with rabbit anti-recombinant human Sp17 [12] and
mouse antiserum against an Sp17 peptide (A9DT; AEWGAK-
VED), prepared as described previously [13]. Mouse myeloma
cell lysate was prepared by homogenization of 2¬10) cells}ml in
PBS (pH 7.4), containing proteasome inhibitors and protease
inhibitor cocktail I (Calbiochem). Following centrifugation at
12000 g, the supernatant was mixed with an equal volume of
sample buffer and a portion loaded on to the SDS gel as
described in [1].
Immunofluorescence
Mouse 3T3 cells growing on microscope slides were washed in
PBS, fixed in methanol at ®20 °C for 10 min, washed, and
stained with antiserum or control serum (1}100 dilution) for
1.5 h at room temperature. Cells were viewed with a Zeiss
fluorescence microscope with a 100¬ oil objective.
Sp17 genomic structure
A total of 16 primers were used to amplify potential intron-
spanning Sp17 genomic DNA fragments from the mouse 129}SvJ
lambda genomic library (Stratagene). Primers were designed
according to the mouse Sp17 sequence reported by Kong et al.
[14]. PCR was performed as described above. When the PCR
product size was larger than the expected cDNA size, the product
was purified using the QIAquick PCR Purification kit (Qiagen)
and cloned into pCR2.12-TOPO vector using the TOPO TA
cloning kit (Invitrogen) for sequencing. The plasmid was purified
using QIAprep Spin Miniprep kit (Qiagen). The exon–intron
junctions were determined by comparing the genomic sequence
with the cDNA sequence.
Multiple sequence alignment and phylogenetic analysis
Sp17 sequence alignment and phylogenetic analyses were per-
formed using GCG Software packages (Genetic Computer
Group, University of Wisconsin, Madison, WI, U.S.A.). Se-
quence alignment was generated by the PILEUP program. The
PAUP program [15] was used to construct the phylogeny of
Sp17. Sp17 has been identified and sequenced from rabbit
(Oryctolagus cuniculus ; [1]), mouse (Mus musculus ; [14]), human
(Homo sapiens ; [12]), baboon (Papio hamadryas ; [16]), macaque
(Macaca fascicularis ; [17]), rat (Rattus noregicus, GenBank2
accession number AJ131888), wallaby (Macropus eugenii,
GenBank2 accession number 3915005), Monodelphis (Mono-
delphis domestica, GenBank2 accession number 3915006), and
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marmoset (Callithrix jacchus, GenBank2 accession number
AF134585). In addition, Macaca mulatta Sp17 cDNA was
sequenced and found to be 100% identical with Macaca
fascicularis (Y. Wen, unpublished work). ‘Zoo’ Southern blots
have shown that Sp17 is also present in dogs and cows, but not
in chickens or yeast (Saccharomyces cereisiae ; [12]).
RESULTS AND DISCUSSION
Sulphated carbohydrate (heparin) binding
Because of Sp17’s ability to aggregate transformed cells via
syndecan heparan sulphate chains [5], and to bind spermatozoa
to the zona pellucida [1], we have investigated the major sulphated
carbohydrate-binding domain in the Sp17 sequence. Four recom-










(Figures 1 and Figure 2A), were examined for their heparin-








all bound ["#&I]heparin–albumin in a saturable
manner, but Sp17 bound somewhat more heparin than the





was at background levels (Figure 2A). Scatchard-plot









binding affinities overlap and were not
significantly different from one another (Figure 1). However,








(Figure 2B). Therefore there appear to be at least
two high-affinity heparin-binding sites in Sp17. The interaction
between recombinant proteins and ["#&I]heparin–albumin is
specific since it can be competed away with increasing amounts
of unlabelled heparin (Figure 2C). The potential heparin-binding
motif, BBXB (where B is any basic amino acid) [19], occurs at
amino acid 49–52 (KREK) and at amino acid 131–134 (KKIR),
consequently heparin binding may be contingent upon at least
one of these sites and the proper conformation of the region
between amino acid residues 61–117, which is the overlapping














does not have heparin-binding activity,
although it does contain amino acid residues 49–52.
Expression of Sp17 in somatic tissues
Although Sp17 was originally described as a sperm- and testis-
specific protein [1], it has now been reported in human metastatic
cell lines derived from an in itro transformed keratinocyte line
(Pam 212) using mRNA differential display and in human
haematopoietic cell lines, myeloma cells, normal peripheral blood
mononuclear cells and sheep lymphocytes [4–6]. Sp17 is thought
to promote cell–cell adhesion through its interaction with
syndecan-1 heparan sulphate chains on the surface of these cells.
To determine whether Sp17 is present in mouse somatic tissues,
Figure 1 Heparin binding of Sp17 recombinant constructs
The KD was calculated based on heparin–albumin having a molecular mass of 102–138 kDa.




Figure 2 Heparin Sp17 binding
(A) Binding of [125I]heparin–albumin to recombinant rabbit Sp17 constructs. Sp17 (E), Sp17-
N1–117 (+), Sp17-N1–60 (_) and Sp17-C61–146 (y). (B) Scatchard plot of [
125I]heparin–albumin
binding to Sp17 (E), Sp17-N1–117 (+) and Sp17-C61–146 (y). (C) Displacement of
[125I]heparin–albumin binding to Sp17 (E), Sp17-N1–117 (+), Sp17-N1–60 (_) and Sp17-
C61–146 (y) with increasing amounts of unlabelled heparin.
PCR was performed on a Mouse Multiple Tissue cDNA Panel I
and on ovary and thymus cDNA, using primers to amplify the
entire mouse Sp17 ORF. The amounts of cDNA were normalized
to six different housekeeping genes in all tissues except ovary and
thymus. The presence of Sp17, as shown by a 450 bp PCR
product, is predominantly in testis, but is also in thymus, ovary,
kidney, skeletal muscle, lung, brain and heart (Figure 3A).
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Figure 3 Somatic Sp17
(A) PCR of Sp17 from different tissues and different stages of embryos. The amounts of cDNA were normalized except in ovary and thymus. Tissues are identified above each lane. The markers
are }X174 RF DNA/Hae III fragments (Gibco BRL). (B) Mouse RNA Master blot probed with Sp17 ORF DNA. The amounts of cDNA were normalized. The tissue identities are : A1, brain ; A2,
eye ; A3, liver ; A4, lung ; A5, kidney ; B1, heart ; B2, skeletal muscle ; B3, smooth muscle ; C1, pancreas ; C2, thyroid ; C3, thymus ; C4, submaxillary gland ; C5, spleen ; D1, testis ; D2, ovary ; D3,
prostate ; D4, epididymis ; D5, uterus ; E1, 7-day embryo ; E2, 11-day embryo ; E3, 15-day embryo ; E4, 17-day embryo ; F1, yeast total RNA ; F2, yeast tRNA ; F3, E. coli rRNA ; F4, E. coli DNA ;
G1, polyadenylated RNA ; G2, Cot 1 DNA ; G3 and G4, mouse DNA. B4, B5, E5, F5, and G5 are blank. (C) Relative intensities of Sp17 gene expression. The intensity of testis Sp17 expression
was arbitrarily assigned as 1.0 and the intensity of Sp17 expression from other tissues was compared relative with the testis. Tissue identities are the same as in (B). (D) Mouse multiple tissue
Western blot. Tissue lysate (75 µg) was loaded into each lane. The blot was probed with affinity-purified rabbit anti-rabbit Sp17 (1 : 500). (E) Western blot following SDS/PAGE on a 4–15% gradient
gel probed with mouse anti-Sp17 peptide (A9DT), lanes 1–3 ; and pre-immune control antibody, lanes 4–6. Lane 1, 20 µl of mouse myeloma cell lysate ; lane 2, 5 µg of mouse recombinant Sp17 ;
lane 3, 9.6 µg of human recombinant Sp17. The doublet band seen is at 24 kDa.
Additionally, Sp17 is present in 11-, 15- and 17-day embryos
(Figure 3A). Sequencing of the Sp17 PCR products from mouse
ovary and kidney revealed that somatic Sp17s have identical
sequences with mouse testis Sp17 (GenBank2 accession number
2842646; [14]).
To confirm the presence of Sp17 in somatic tissues, the
expression of Sp17 mRNA was examined by probing a mouse
RNA Master blot with the Sp17 ORF cDNA. Sp17 mRNA is
expressed in all tissues, including liver and spleen, as well as in
11-, 15- and 17-day embryos (Figure 3B). It is not expressed
in yeast or Escherichia coli. When the level of Sp17 mRNA
expression was analysed, the highest expression is found in the
testis as expected (Figure 3C). In comparison with testis, brain
and heart expressed " 40% of the testis level, whereas eye, liver,
kidney, skeletal muscle, thyroid and uterus expressed " 20% of
the testis level. Low expression (! 20%) of Sp17 mRNA is
found in lung, smooth muscle, pancreas, thymus, submaxillary
gland, spleen, ovary, prostate and epididymis. In embryos, Sp17
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Figure 4 Immunofluorescent localization of Sp17 in mouse 3T3 cells with mouse anti-A9DT antiserum (B) and pre-immune control antibody (D)
Phase and contrast views are shown in (A) and (C) respectively. Magnification ¬1000.
mRNA expression is the highest in 7-day embryos and lowest in
15-day embryos. To further confirm Sp17 in somatic tissues,
heart and kidney Sp17 mRNAs were obtained from mouse heart
and kidney polyadenylated RNA and sequenced. The somatic
sequences are identical with mouse testis Sp17 sequence [14].
Therefore we conclude that Sp17 mRNA is expressed in somatic
mouse tissues and that it is identical with the testis form.
To confirm that Sp17 mRNA is translated in somatic tissues,
a mouse multiple-tissue Western blot was probed with affinity-
purified rabbit anti-rabbit Sp17 antibodies [11]. The antibody
recognized bands at 24 kDa and 18 kDa (Figure 3D). The
strongest antibody staining is seen in the testis, followed by lung,
spleen and ovary. Weaker staining was seen in liver, brain,
kidney, heart and pancreas. In the testis, the difference between
the 24 kDa and 18 kDa bands is accounted for by the loss of the
C-terminal calmodulin-binding domain [11].
Mouse myeloma cell lysates were probed on a Western blot for
Sp17 and exhibit the same doublet of antibody staining bands at
26 kDa (Figure 3E, lane 1) as mouse and human recombinant
Sp17 (Figure 3E, lanes 2 and 3). The presence of Sp17 in mouse
3T3 cells was also shown by Western blots (results not shown)
and confirmed by immunofluorescence (Figure 4B). Sp17 is
present throughout the cytoplasm and is particularly concen-
trated around the nucleus. Whether Sp17 is present on the
surface of 3T3 cells was not determined; however, Sp17 is
present on the surface of B-lymphocytes and granulocytes. It
is weakly expressed on the surface of T lymphocytes and mono-
cytes, and present on the surface of most malignant B and T
lymphocyte cell lines (H. M. Lacy and R. D. Sanderson, personal
communication).
Mouse Sp17 genomic structure
Sp17 is a highly conserved protein whose sequence is identical in
both somatic and testicular cells. In comparing mouse, rabbit
and human sequences [12], a striking degree of identity at both
the DNA and protein level was observed. To obtain a complete
picture of Sp17, and the high-affinity heparin-binding site in
Figure 5 Schematic diagram of the mouse Sp17 genomic structure
Positions of the start (ATG) and the stop (TGA) codons are indicated.
Sp17 located between amino acids 61–117, we mapped the
mouse Sp17 genomic sequence. Figure 5 is a schematic diagram
of the mouse Sp17 genomic structure in the coding region. The
gene is approx. 6.5 kb and contains four exons. The sizes of
the exons and introns and exon–intron junctions are summarized
in Table 1. The three exons in the ORF encode the highly con-
served N-terminal domain (amino acids 1–75), a variable middle
domain(aminoacids76–101)andaconservedcalmodulin-binding
C-terminal domain (amino acids 102–149) [11]. The mouse
genomic structure approximates the structure–function protein
motif, each exon encoding a functional domainof the protein.Un-
like human Sp17, in which the N-terminal 75 amino acids are
contained in two exons [12], the N-terminal 75 amino acids of
mouse Sp17 contain only one exon (Figure 5). Therefore
although mouse and human Sp17 N-terminal DNA (93%
identity) and protein (94% identity) sequences are highly con-
served, their genomic structures are not conserved.
Comparison of mammalian Sp17s
Using the mouse genomic structure as a model for viewing the
alignment of Sp17 protein sequences, the structure–function
motif can be clearly seen. Figure 6 shows the alignment of Sp17
protein sequences from eutherian and marsupial mammals,
including rat, mouse, macaque, baboon, human, marmoset,
rabbit, Monodelphis and wallaby. Exon 2 contains the highly
conserved dimer interaction site, exon 3 contains the hyper-
variable domain and exon 4 the calmodulin-binding site. The
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Table 1 Exon–intron junctions of the mouse Sp17 gene
mRNA positions are as described in [14]. The intron sequences are shown in lower case letters and the exon sequences are shown in upper case.
Exon Amino acids mRNA position Exon size (bp) 5«-Intron–exon junction 3«-Exon–intron junction Intron size (bp)
1 ®94 to ®30 65 GAAGAG–gtgagg 1575
2 1–75 ®29 to ­225 254 ctttag-GTACCA TTCAAG–gtatag 1760
3 76–101 ­226 to ­303 78 ttctag-GAACAA CCCTTC–gtacgt 2549
4 102–149 ­304 to ­489 186 atgaag-GAGGAG
Figure 6 Alignment of Sp17 protein sequences
The species are identified by their common names. Residues identical to the top sequence are indicated by dots ([) and gaps inserted for improved sequence alignment are indicated by dashes
(–). Positions of cysteines are boxed. The first sequence repeat in marmoset is wavy underlined, the second repeat is double underlined and the third repeat shared with other primates is dotted
underlined. The IQ motif is overlined. Exons indicated are from the mouse sequence.
most striking feature is that the N-terminal 75 amino acids in
mouse exon 2 are highly conserved, 68 out of 75 (90%) residues
are identical. Completely identical N-terminal sequences are
found in the order Rodentia and in the primate suborder
Catarrhini (macaque, baboon and human). Marmoset has a
cysteine in position 10 that is not present in any other species. In
this region, all Sp17s showed similarities to the dimer interaction
site of the cAMP-dependent protein kinase IIα regulatory subunit
[8–10]. This domain also has similarities with the N-terminal of
the rhophilin-binding protein, ropporin [20], an AKAP-binding
protein. Based on the RIIα [10] and Sp17 sequences, these data
suggest that Sp17 probably dimerizes and binds to AKAPs.
AKAP-bound Sp17 could provide calmodulin and}or sulphated
carbohydrates in the correct location for other cell functions.
The middle domain of Sp17, which is mouse exon 3 (amino
acids 76–101; Table 1), contains the central region critical for the
conformation of the high-affinity heparin-binding sites (Figure 1)
and exhibits the greatest sequence divergence among all the
sequences studied. As shown in Figure 6, this region in the mar-
moset is composed of three repeated sequences. The first two
repeats (positions 76–104 and 105–133) are unique (underlined in
Figure 6), whereas the third repeat (positions 134–162) is shared
by other primates (dotted underline, Figure 6). This domain may
be under more selective pressure than the other domains because
of the different sulphated carbohydrates that each species
encounters, which may, in turn, require variability and sequence
repeats.
Both wallaby and Monodelphis have stretches of amino acids
(positions 119–133) that are not found in other species. Ad-
ditionally, Monodelphis Sp17 has a unique stretch of amino acids
(positions 175–181) not found in any other species, including
wallaby. It should also be noted that the cysteine content of
Sp17 found at position 151 in Rodentia, marmoset and rabbit is
not found in Catarrhini or marsupials.
The C-terminal domain of Sp17 sequences contains the
calmodulin-binding site [11]. Characterized by the signature IQ
motif, IQXXXRGXXXR, it is found in all species (Figure 6). In
the rabbit this site is functional [11] and therefore likely to be
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Figure 7 Phylogenetic tree constructed using Sp17 protein sequences
The species are identified by their common names. The tree has a consistency index of 0.9451.
Numbers above tree branches indicate numbers of changes that occur along the branch.
functional in all the other species. The PKC phosphorylation site
found in human growth-associated protein-43 is not present in
the Sp17 IQ motif, consequently rabbit Sp17 and calmodulin
interaction was not inhibited by PKC phosphorylation in itro
(results not shown). However, PKC phosphorylation of Sp17
was inhibited by calmodulin. Sp17 sequences showed consider-
able variability downstream of the IQ motif (Figure 6).
Phylogeny of Sp17
A phylogeny of Sp17 was constructed with Sp17 protein
sequences by maximum-parsimony analysis using the exhaustive
search method (Figure 7; [15]). Ten optimal trees with the same
consistency index were obtained. The phylogeny shown in Figure
7 was chosen because the same branch pattern was generated by
maximal-likelihood analysis using Sp17 DNA sequences. The
grouping of rabbits with primates is consistent with a previous
report [20] demonstrating that Lagomorpha is more closely
related to primates and tree shrews than it is to rodents [21].
CONCLUSIONS
Sp17 is a ubiquitous molecule with four exons (Figure 5) that ex-
press three functional domains: an N-terminal domain similar to
the dimer interaction site of the cAMP-dependent protein kinase
IIα regulatory subunit [8–10], a C-terminal calmodulin-binding
domain [11], and a central sulphated carbohydrate-binding do-
main (Figures 1 and 2). Although Sp17 expression is highest
in the testis, it has been found in all of the tissues examined
(Figures 3 and 4) and is conserved throughout all the
mammalian species examined (Figures 6 and 7). The gene is
induced in metastatic cells and during mucosal immune responses
[4,6] and appears to play an important role in cell migration
and}or adhesion as well as in fertilization [1,2,5]. This is further
supported by the recent detection of Sp17 on the surface of
Received 14 February 2001/16 March 2001 ; accepted 2 April 2001
normal B-lymphocytes and granulocytes and weakly on the
surface of T lymphocytes and monocytes (H. M. Lacy and R. D.
Sanderson, personal communication).
Support for this project was provided by NIH grant U54HD29099. The authors thank
Professor R. D. Sanderson, Arkansas Cancer Research Center, Little Rock, AR,
U.S.A., for making the submitted manuscript (H. M. Lacy and R. D. Sanderson,
personal communication) available to us. The λZAP tammar wallaby (Macropus
eugenii ) testis cDNA library was a gift from Dr Karen Mate and Dr Merrilee Harris
(Macquarie University, New South Wales, Australia).
REFERENCES
1 Richardson, R. R., Yamasaki, N. and O’Rand, M. G. (1994) Sequence of a rabbit
sperm zona pellucida binding protein and localization during the acrosome reaction.
Dev. Biol. 165, 688–701
2 O’Rand, M. G., Widgren, E. E. and Fisher, S. J. (1988) Characterization of the rabbit
sperm membrane autoantigen, RSA, as a lectin-like zona binding protein. Dev. Biol.
129, 231–240
3 Yamasaki, N., Richardson, R. T. and O’Rand, M. G. (1995) Expression of the rabbit
sperm protein Sp17 in COS cells and interaction of recombinant Sp17 with the
rabbit zona pellucida. Mol. Reprod. Dev. 40, 48–55
4 Dong, G., Loukinova, E., Smith, C. W., Chen, Z. and Van Waes, C. (1997) Genes
differentially expressed with malignant transformation and metastatic tumor
progression of murine squamous cell carcinoma. J. Cell. Biochem. Suppl 28/29,
90–100
5 Lacy, M. and Sanderson, R. (1999) Sperm protein Sp17 promotes cell-cell adhesion
through interaction with syndecan-1 heparan sulfate chains. Mol. Biol. Cell 10, 459a
6 Tatlow, D., Brownlie, R., Babiuk, L. A. and Griebel, P. (2000) Differential display
analysis of gene expression during the induction of mucosal immunity.
Immunogenetics 52, 73–80
7 O’Rand, M. G. and Widgren, E. E. (1994) Identification of sperm antigen targets for
immunocontraception : B-cell epitope analysis of Sp17. Reprod. Fertil. Dev. 6,
289–296
8 Taylor, S., Buechler, J. A. and Yonemoto, W. (1990) cAMP dependent protein kinase :
Framework for a diverse family of regulatory enzymes. Ann. Rev. Biochem. 59,
971–1005
9 Huang, L. J., Durick, K., Weiner, J. A., Chun, J. and Taylor, S. S. (1997) D-AKAP2, a
novel protein kinase A anchoring protein with a putative RGS domain. Proc. Natl.
Acad. Sci. USA 94, 11184–11189
10 Newlon, M. G., Roy, M., Morikis, D., Hausken, Z. E., Coghlan, V., Scott, J. D. and
Jennings, P. A. (1999) The molecular basis for protein kinase A anchoring revealed
by solution NMR. Nature Structure Biol. 6, 222–227
11 Wen, Y., Richardson, R. T. and O’Rand, M. G. (1999) Processing of the sperm
protein Sp17 during the acrosome reaction and characterization as a calmodulin
binding protein. Dev. Biol. 206, 113–122
12 Lea, I. A., Richardson, R. T., Widgren, E. E. and O’Rand, M. G. (1996) Cloning and
sequencing of cDNAs encoding the human sperm protein, Sp17. Biochim. Biophys.
Acta 1307, 263–266
13 Lea, I. A., van Lierop, M. J. C., Widgren, E. E., Grootenhuis, Y., Wen, Y., van Duin,
M. and O’Rand, M. G. (1998) A chimeric sperm peptide induces antibodies and
strain-specific reversible infertility. Biol. Reprod. 59, 527–536
14 Kong, M., Richardson, R. T., Widgren, E. E. and O’Rand, M. G. (1995) Sequence and
localization of the mouse sperm autoantigenic protein, Sp17. Biol. Reprod. 53,
579–590
15 Swofford, D. L. (1993) PAUP : Phylogenetic analysis using parsimony, version 3.1.1,
Smithsonian Institution, Washington, D. C.
16 Adoyo, P. A., Lea, I. A., Richardson, R. T., Widgren, E. E. and O’Rand, M. G. (1997)
Sequence and characterization of the sperm protein Sp17 from the baboon.
Mol. Reprod. Dev. 47, 66–71
17 Lea, I. A., Kurth, B. and O’Rand, M. G. (1998) Immune response to immunization
with sperm antigens in the macaque oviduct. Biol. Reprod. 58, 794–800
18 Scatchard, G. (1949) The attraction of proteins for small molecules and ions. Ann.
N. Y. Acad. Sci. 51, 660–672
19 Hileman, R. E., Fromm, J. R., Weiler, J. M. and Linhardt, R. J. (1998)
Glycosaminoglycan-protein interactions : definition of consensus sites
in glycosaminoglycan binding proteins. BioEssays 20, 156–167
20 Fujita, A., Nakamura, K., Kato, T., Watanabe, N., Ishizaki, T., Kimura, K., Mizoguchi,
A. and Narumiya, S. (2000) Ropporin, a sperm-specific binding protein of rhophilin,
that is localized in the fibrous sheath of sperm flagella. J. Cell Sci. 113, 103–112
21 Graur, D., Duret, L. and Gouy, M. (1996) Phylogenetic position of the order
Lagomorpha (rabbits, hares and allies). Nature 379, 333–335
# 2001 Biochemical Society
